Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER).
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms TWISTER
- 10 Dec 2010 New trial record
- 03 Dec 2010 Additional lead investigator (Epidem M) identified as reported by ClinicalTrials.gov.